Comorbidities May Predict Non-Home Discharge After Hysterectomy

Share this content:
Identifying patients at risk of non-home discharge can help discussions of recovery expectations and discharge planning.
Identifying patients at risk of non-home discharge can help discussions of recovery expectations and discharge planning.

Presence of comorbidities is associated with non-home discharge after hysterectomy for gynecologic malignancy, according to a study presented at the 48th Annual Meeting of the Society of Gynecologic Oncology.1

Identifying patients at risk of non-home discharge can aid in discussion of recovery expectations, early discharge planning, and hospital resource allocation. The purpose of this study was to develop a preoperative risk-scoring model to identify patients at high risk of non-home discharge after surgery for a gynecologic malignancy.

This retrospective cohort study evaluated data from 2134 women who underwent hysterectomy for gynecologic malignancy between January 2013 and April 2015. A nanogram was developed using a multivariable model.

In the study, 3.1% of the cohort was not discharged to home after undergoing hysterectomy, and there was no difference in non-home discharge rate between gynecologic tumor types. The most frequent non-home destination was skilled nursing facilities (68.2%) and inpatient rehabilitation (19.7%). Women with a non-home discharge were more likely to have a longer hospitalization compared with patients who were discharged to home (10 days vs 3 days; P <.0001).

Factors associated with a non-home discharge included comorbidities such as hypertension, diabetes, coronary artery disease, dyspnea, arrhythmia, and history of deep vein thrombosis and pulmonary embolism. Non-home discharge was significantly more likely in women with 1 risk factor (adjusted odds ratio [OR], 3.4; P =.03) or 2 or more risk factors (adjusted OR, 5.1; P =.003) compared with women with no risk factors.

Non-home discharge was also associated with undergoing laparotomy vs laparoscopy, and older age (70 years or older).

Reference

1. Penn CA, Kamdar NS, Morgan DM, et al. Preoperatively predicting non-home discharge after surgery for gynecologic malignancy. Presented at: 48th Annual Meeting of the Society of Gynecologic Oncology; March 12-15, 2017; National Harbor, MD.

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs